EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Covalent Inhibitor Fragment for the SARS-CoV-2 Main Protease Identified by Target-Specific Deep Learning

Weijun Zhou iD, Angel D Oliviera, Xuhang Dai, Jeffrey S Mugridge iD, Yingkai Zhang iD

ACS Chemical Biology · 15.05.2026 · 21 (5) · 1112-1124

DOI: 10.1021/acschembio.6c00120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 01.05.2026. Verfasst von Weijun Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, New York University, New York, New York 10003, United States. Hauptthemen laut MEDLINE: SARS-CoV-2, Deep Learning, Antiviral Agents, Protease Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NIH Office of the Director.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Deep LearningAntiviral AgentsProtease InhibitorsCoronavirus 3C ProteasesBetacoronavirusHumansDrug DiscoveryModels, Molecular

Substanzen

Antiviral AgentsProtease InhibitorsCoronavirus 3C Proteases3C-like proteinase, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Chemistry, New York University, New York, New York 10003, United States.
  • Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, United States.
  • Simons Center for Computational Physical Chemistry at New York University,New York, New York 10003, United States.
  • NYU-ECNU Center for Computational Chemistry at NYU Shanghai, Shanghai 200062, China.

ORCID-Profile: Weijun Zhou, Jeffrey S Mugridge, Yingkai Zhang

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • NIH Office of the Director
  • National Institute of General Medical Sciences

Zitieren

APA

Zhou, W., D Oliviera, A., Dai, X., Mugridge, J. S., & Zhang, Y. (2026). A Novel Covalent Inhibitor Fragment for the SARS-CoV-2 Main Protease Identified by Target-Specific Deep Learning. ACS Chemical Biology, 21(5), 1112-1124. https://doi.org/10.1021/acschembio.6c00120

Vancouver

Zhou W, D Oliviera A, Dai X, Mugridge JS, Zhang Y. A Novel Covalent Inhibitor Fragment for the SARS-CoV-2 Main Protease Identified by Target-Specific Deep Learning. ACS Chemical Biology. 2026;21(5):1112-1124. doi:10.1021/acschembio.6c00120

BibTeX
@article{Zhou2026,
  author = {Zhou, Weijun and D Oliviera, Angel and Dai, Xuhang and Mugridge, Jeffrey S and Zhang, Yingkai},
  title = {A Novel Covalent Inhibitor Fragment for the SARS-CoV-2 Main Protease Identified by Target-Specific Deep Learning},
  journal = {ACS Chemical Biology},
  year = {2026},
  volume = {21},
  number = {5},
  pages = {1112--1124},
  doi = {10.1021/acschembio.6c00120}
}
Kostenlos starten →